Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

IIROC Trading Halt - VIV

Canada NewsWire January 26, 2021

Avivagen Announces Six Tonne Order of OxC-beta(TM) Livestock from New Customer in Mexico

Business Wire January 26, 2021

TMX Group, Avivagen, C-Suite at The Open

Canada NewsWire December 18, 2020

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2020

Business Wire December 16, 2020

Avivagen Announces Expansion of Non-Dilutive Financing in Support of Increased Product Sales

Business Wire November 25, 2020

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Business Wire November 19, 2020

Avivagen Inc. Announces Proposed Extension of Warrants

Business Wire November 13, 2020

Avivagen Announces Non-Dilutive Financing in Support of Increased Product Sales

Business Wire October 15, 2020

Avivagen Announces Record Four Tonne Order From UNAHCO

Business Wire October 13, 2020

Avivagen Receives Multiple New Orders and Joins Influential Industry Associations in Mexico

Business Wire October 6, 2020

Avivagen Receives 10 Tonne Purchase Order for OxC-beta Livestock from Large North American Client

Business Wire September 28, 2020

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Business Wire September 15, 2020

Avivagen Inc. Announces Proposed Extension of Warrants

Business Wire September 9, 2020

Avivagen Inc. Announces Record Revenue for the Third Quarter Ending July 31, 2020

Business Wire September 3, 2020

AVIVAGEN to Present at The LD 500 Virtual Conference

Accesswire August 31, 2020

Avivagen Announces Publication of Scientific Paper in British Journal of Nutrition

Business Wire August 18, 2020

Avivagen Announces Payment of Consulting Fee

Business Wire August 14, 2020

Avivagen Secures First Sale of OxC-beta(TM) Livestock in Brazil

Business Wire August 12, 2020

LD Micro Announces Preliminary List of Presenters for the LD 500

Accesswire August 5, 2020

Avivagen: The OxC-beta(TM) Technology Is A True Game Changer

Newsfile July 23, 2020